Elekta fortifies treatment planning offering with acquisition of ProKnow

Report this content

STOCKHOLM, August 29, 2019 – Elekta (EKTA-B.ST) announced today that it has acquired ProKnow Systems, LLC, in order to expand its offering of cloud-based solutions for advanced radiation therapy. With ProKnow’s products, such as ProKnow DS, Elekta’s customers will have access to high-quality, cloud-based, treatment planning analytics to standardize their practices.

ProKnow DS allows collective data from patient groups to be analyzed and offer big data support to oncology teams. The solution can also streamline workflow challenges and improve contouring accuracy and treatment plan quality. The technology is vendor agnostic and is used today by healthcare networks with a variety of treatment planning systems.

Ben Nelms, Ph.D., Co-Founder and Director at ProKnow said: “We are very pleased to join the Elekta team. It is truly a great fit, not just in terms of technology, but also mindset. ProKnow and Elekta have a fruitful history of collaboration – such as working together to establish programs for the continual improvement of anatomy contouring and treatment plan quality – and now an even brighter future. We are excited to help stimulate Elekta’s ambitious digital roadmap, and to provide the radiation therapy community with some of the most innovative, useful, and intuitive tools they have ever seen.”

Elekta CEO, Richard Hausmann, said: “This strategic acquisition supports our Elekta Digital initiative and will contribute to accelerating our big data and artificial intelligence efforts as we help healthcare providers to improve decision support, identify best practices and ensure a high quality of care. The solutions that ProKnow brings are especially well-suited to many of our large customers and their need for data management, analytics and workflow automation across their oncology networks. We’re also looking forward to accessing the expertise and competencies within the ProKnow team to continue enhancing analytics under the Elekta umbrella.”

# # #

For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46 70 410 7180, e-mail:
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail:
Time zone: CET: Central European Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.



Documents & Links